Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1998
12/23/1998CA2295440A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998CA2294549A1 Heterocyclic substituted piperidines and uses thereof
12/23/1998CA2294379A1 3-benzylpiperidine
12/23/1998CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998CA2294047A1 Crystalline roxifiban
12/23/1998CA2292883A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
12/23/1998CA2291442A1 Novel guanidine mimics as factor xa inhibitors
12/23/1998CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998CA2241164A1 Apo b-secretion/mtp inhibitor hydrochloride salt
12/22/1998US5852210 Cinnamic acid derivatives
12/22/1998US5852059 Use of droloxifene for the treatment of protastic disease, endometriosis and obesity
12/22/1998US5852058 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
12/22/1998US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998US5852047 Pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
12/22/1998US5852044 Use of NK1 receptor antagonists for preparing cardio-regulatory drugs
12/22/1998US5852031 2,7-substituted octahydro-1H-pyrido 1,2-a!pyrazine derivatives
12/22/1998US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same
12/22/1998US5852002 Treatment of conditions and disease
12/22/1998US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/22/1998US5851996 Materials and methods for treatment of plaquing diseases
12/22/1998US5851990 bFGF mutein and its production
12/22/1998US5851814 Human elastate IV
12/22/1998US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus
12/22/1998US5851786 Product and process to regulate actin polymerization
12/22/1998US5851521 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
12/22/1998CA2103826C 17-(3-furyl) and 17-(4-pyridazinyl) -5.beta.,14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998WO1998056916A1 Aprotinin variants with improved properties and bikunins of aprotinin variants
12/17/1998WO1998056913A1 Smad6 and uses thereof
12/17/1998WO1998056907A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056783A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
12/17/1998WO1998056759A2 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
12/17/1998WO1998056409A1 USE OF FACTOR XIIIa INHIBITORS TO TREAT ATHEROSCLEROSIS
12/17/1998WO1998056383A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998WO1998056376A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998WO1998056365A1 COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT
12/17/1998WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
12/17/1998WO1998040087A3 USE OF HUMAN α1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
12/17/1998WO1998033919A3 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
12/17/1998WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998WO1998023299A3 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
12/17/1998DE19826781A1 Pentaerythritol derivatives
12/17/1998DE19725014A1 Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten Aprotinin variants with improved properties and Bikunine of aprotinin
12/17/1998CA2295704A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998CA2293733A1 Mycardium-and skeletal muscle-specific nucleic acid, its preparation and use
12/17/1998CA2293407A1 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
12/17/1998CA2293400A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998CA2293302A1 Use of factor xiiia inhibitors to treat atherosclerosis
12/17/1998CA2292339A1 Smad6 and uses thereof
12/16/1998EP0884387A2 Human 7-transmembrane receptor HLWAR77
12/16/1998EP0884386A1 Sodium channel receptor
12/16/1998EP0884326A2 Antithrombitic compound
12/16/1998EP0884319A2 [1,3]oxazino[3,2-A]indole derivative
12/16/1998EP0884316A1 Quinazoline-4-one AMPA antagonists
12/16/1998EP0884310A1 Quinazolin-4-one ampa antagonists
12/16/1998EP0884054A2 Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist for the treatment of cardiovascular illnesses
12/16/1998EP0883405A1 Amidino protease inhibitors
12/16/1998EP0883401A1 At1 receptor antagonist for the stimulation of apoptosis
12/16/1998EP0883343A1 Method for treating ischemic tissue
12/16/1998EP0699191B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/16/1998EP0687253B1 4-aminopyridines, process for preparing the same and medicaments containing the same
12/16/1998EP0592453B1 Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, their preparation and their use
12/16/1998CN1202168A Quinolein-2(1H)-one derivatives as serotonin antagonists
12/16/1998CN1202152A 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
12/16/1998CN1201685A Ginkgo and calcium capsule
12/16/1998CN1201684A Capsule of ginkgo and garlic extracts
12/16/1998CN1041203C Preparation of pyrazolopyridine compound
12/15/1998US5849930 Pyrazolidine derivative radical scavenger brain-infarction depressant and brain-edema depressant
12/15/1998US5849919 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor anonist activity
12/15/1998US5849896 α-subunit of the Mac-1 leukocyte adhesion receptor
12/15/1998US5849889 Oligosaccharide-containing 14 aminosteroid compounds and novel diastereoselective aminosteroid process chemistry
12/15/1998US5849865 Peptides for altering bone resorption, angiogenesis and restenosis
12/15/1998US5849799 Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
12/15/1998US5849796 Ortho-substituted benzoil acid derivatives
12/15/1998US5849794 Guanylhydrazones and their use to treat inflammatory conditions
12/15/1998US5849791 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
12/15/1998US5849788 Compound for treatment of cardiac arphythmia, synthesis, and methods of use
12/15/1998US5849781 Tricyclic amides
12/15/1998US5849775 Substituted benzoylguanidines process for their preparation, their use as a medicament or diagnostic, and pharmaceutical containing them
12/15/1998US5849770 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
12/15/1998US5849755 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
12/15/1998US5849753 Pyridyl imidazole derivatives and processes for the preparation thereof
12/15/1998US5849751 Amides and sulphonamides of benzylamines having heterocyclic substituents
12/15/1998US5849749 6-(hydroxymethyl-ethyl)pyridines
12/15/1998US5849746 Substituted 1,4-piperazine-heteroaryl derivatives as 5-HT1D receptor agonists
12/15/1998US5849745 N-benzylpiperazine compounds
12/15/1998US5849740 Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes
12/15/1998US5849739 5-arylindole derivatives
12/15/1998US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998US5849709 Saccharopeptides and derivatives thereof
12/15/1998US5849692 Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors
12/15/1998US5849578 Compositions and methods for the treatment and diagnosis of cardiovascular using RCHD528 as a target
12/15/1998US5849507 Methods to diagnose thrombosis by measuring activation peptide
12/15/1998US5849485 Liver enriched transcription factor
12/15/1998US5849337 Method of enhancing magnesium absorption and prevention of atherosclerosis
12/15/1998CA2163667C Imidazole lipoxygenase inhibitors
12/15/1998CA2160462C Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
1 ... 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 ... 1595